Black Diamond Therapeutics (BDTX) Enterprise Value (2018 - 2026)
Black Diamond Therapeutics (BDTX) posted Enterprise Value of -$118.3 million for Q1 2026, up 8.08% on a QoQ basis from -$128.7 million in Q4 2025, and up 22.4% year-over-year from -$96.6 million in Q1 2025.
Black Diamond Therapeutics (BDTX) Enterprise Value (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics' Enterprise Value history runs 9 years deep, the most recent figure standing at -$118.3 million for Q1 2026.
- Quarterly Enterprise Value rose 22.4% year-over-year to -$118.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$118.3 million (up 22.4% YoY) and the FY2025 annual result came in at -$128.7 million, down 30.51% from the prior year.
- Enterprise Value was -$118.3 million for Q1 2026 at Black Diamond Therapeutics, up from -$128.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$89.5 million in Q2 2023 and bottomed at -$179.7 million in Q1 2022.
- A 5-year average of -$129.6 million and a median of -$128.7 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value surged 44.36% — and 2024, when it slumped 37.36%.
- Black Diamond Therapeutics' Enterprise Value stood at -$122.8 million in 2022, then fell by 7.0% to -$131.4 million in 2023, then increased by 24.98% to -$98.6 million in 2024, then plunged by 30.51% to -$128.7 million in 2025, then rose by 8.08% to -$118.3 million in 2026.
- Business Quant data shows BDTX's Enterprise Value at -$118.3 million in Q1 2026, -$128.7 million in Q4 2025, and -$135.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | -118.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118.26 Mn |
| Dec 31, 2025 | -128.65 Mn |
| Sep 30, 2025 | -135.50 Mn |
| Jun 30, 2025 | -142.83 Mn |
| Mar 31, 2025 | -152.40 Mn |
| Dec 31, 2024 | -98.58 Mn |
| Sep 30, 2024 | -112.68 Mn |
| Jun 30, 2024 | -122.97 Mn |
| Mar 31, 2024 | -115.20 Mn |
| Dec 31, 2023 | -131.40 Mn |
| Sep 30, 2023 | -144.26 Mn |
| Jun 30, 2023 | -89.53 Mn |
| Mar 31, 2023 | -103.37 Mn |
| Dec 31, 2022 | -122.81 Mn |
| Sep 30, 2022 | -144.18 Mn |
| Jun 30, 2022 | -160.89 Mn |
| Mar 31, 2022 | -179.74 Mn |
| Dec 31, 2021 | -209.79 Mn |
| Sep 30, 2021 | -235.01 Mn |
| Jun 30, 2021 | -263.47 Mn |